RedHill’s Phase II/III COVID-19 research underway
The company’s studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.
The company’s studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.
Symbiosis Pharmaceutical Services reported a successful audit outcome by the UK government regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) for its Scottish production site.
Sanofi, Vibalogics and Evelo Biosciences are among the companies welcoming new faces to top jobs.